chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  Fully vaccinated, admitted for failure to thrive and hypotension, incidentally COVID positive
My tip of my tongue was a little numb after the shot but mainly the thing that has affected me since the day after the shot is tinnitus.
VACCINE WAS THAWED ON 4/30/21 WHEN RECEIVED,  AFTER RECEIVING, VACCINE WAS PLACED IN FREEZER AND FROZEN.  TAKEN OUT OF FREEZER AND PLACED IN FRIG ON 5/12 TO THAW.   VACCINE WAS GIVEN TO PT ON 5/13.   WHEN OPENING 2ND VIAL OF VACCINE, SAW THE EXPIRATION DATE OF 5/10/21 ON VIAL, (SPOKE WITH HOSP WHO DISPENSED VACCINE TO US AND FOUND OUT VIAL EXPIRED ON 5/10/21 DUE TO THAWING)
This patient has Guillain Barre' Syndrome, He was hospitalized.  Follow up 07/06/2001: "Final diagnosis was GBS.  Patient experienced other previous illnesses or medical conditions before the onset of GBS, however, it was not stated.  Patient was previously vaccinated with INfluenza prior."
Fever 104 degrees,not resolved with Tylenol x48 hrs. Joint pain, knees, feet, hands. Swollen lymph nodes, Right cervical & bilateral axillary nodes. Fine rash, arms bilaterally & on her neck. She was seen at a local walk-in clinic but cannot recall the exact date. Today, 6-18-12, she is at Co Health Dept., still complaining of joint pain in her fingers, knees, ankles and the arches of her feet.
Two  hours after receiving  vaccine the same side of my forearm felt burning and  tingling. Pain persisted the next few hours into my hand and my wrist, palm of my hand and fingers felt numbness and tingling.  The pain and numbness in the next couple of days radiated to the back of my elbow and to my underarm. The pain continued for 2 weeks after getting the vaccine. I saw a NP on 1/26 and got a prescription for a 6 day dose of steroids. It helped initially the pain resolved while taking the medication. 2 days after completion of the steriods the pain  returned but not as strong. I continue to have intermittent numbness and tingling in my hands and pain in my wrist, palm and arm. I am waiting to see my PCP in March.
SMALL RED AREA WITH URTICURIAL LESION AT LEFT UPPER SUBCUTENEOUS TISSUE. SUPPORTIVE CARE GIVEN,BENADRYL ADVISED WITH PLANS FOR ANTIBIOTIC IF CONDITION WORSENS.
Approximately 18 hrs. after receiving menactra vaccine client began vomiting (lasting 2 days) and experienced a severe headache with light sensitivity (lasting 3 days). Client denies fever, neck/back stiffness or weakness of extremities. He states he fully recovered 7 days post vaccination.
Shortness of breath, swelling, diaphoresis. Diagnosed with myocarditis and acute heart failure which led to cardiogenic shock.
Maderno shot 2  Day 1-shot site sore  Day 2-4-left entire arm sore, numb , head aches, off balance, tired- stayed at home rested drank fluids, Tylenol   Ongoing- since shot 2- been to Dr, have ongoing balance issues, sounds seem over sensitive, head fog, weird feeling in head, mri scheduled on head  , 5/6/2021,
Vaccines administered 9:45am.  Mother reported fever in child at 12:30 - 1 am lasting 4 hours and child lethargic in AM with fever of 101 - she gave Tylenol 4, within 20 hours fever at 100.  Today, vomiting abated.  "Reaction" began approximately 14 hours after vaccine.  Child had similar reaction on #2 DTAP but tolerated #3 without problems.  F/U call 9/10 - vomiting began between 1 - 1:30 am.  Today she has a 99 temperature, feeling better.
A non-serious spontaneous report of administration to asthmatic was received from a mother/consumer concerning a seven-year-old female. Patient's past medical history includes asthma. No concomitant medication was reported for this patient. On 30-Dec-2010, the patient received FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information received on 10-Mar-2011 and incorporated into case: no late occurring adverse events.
FORGOT TO TAKE THE LAST DOSE; This spontaneous case report was received from a nurse (PVX2019-678) on 19-Mar-2019. It described a 20-year-old female consumer who "forgot to take the last dose". The consumer was receiving Vivotif for typhoid prophylaxis.  It was reported that the consumer took the three doses of Vivotif on 11-Mar-2019, 13-Mar-2019, and 15-Mar-2019, and then forgot the last dose.  The action taken with Vivotif with respect to the event "forgot to take the last dose" was not applicable.  The clinical outcome of the event "forgot to take the last dose" was unknown.  Company's Comment: The causality of the event "forgot to take the last dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "forgot to take the last dose" was considered as not applicable
Vaccines 7/1/03 pt showed mother 7/3/03 - redness, itching and swelling at shot sites; left upper arm 7 x 9 cm, right upper arm 2 x 2 cm - erythema with slight induration, warm, blanching, non-tender, itching. Benadryl/hydrocortisone resolving by one week.
Information has been received from a pharmacist concerning a 69 year old female who on 16, Mar 2007 was vaccinated with a dose of zoster vaccine live (Oka/Merck) rather that varicella virus vaccine live (Oka/Merck) (MSD). It was reported that there was confusion with which vaccine the patient was supposed to get after she lost her prescription and both vaccines were on back order. Unspecified medical attention was sought. At the time of the report the patient had not had any adverse reactions. There was no product quality complaint involved. No further information was available. Additional information has been requested.
pt recvd vax 28JUN94 1130AM & pt became faint p/1st inject of RIG in arm; pt's neck swelling; referred to ER; pt was seen in ER w/dx acute pharnogospasm & bronchopasm due to poss rabies vax & emotional status;
This spontaneous report was received from a pharmacist and refers to a male patient of unknown age. No pertinent medical history, concurrent conditions, drug reactions, allergies or concomitant medications were reported. On 01-JUN-2016 the patient was vaccinated with a dose of ZOSTAVAX (dose and frequency not specified) (lot number and expiration date were not reported). The reporting pharmacist reported that the patient stated that the vaccine was administered "to his ear", however the pharmacist who administered ZOSTAVAX stated that the vaccine was administered subcutaneously to the deltoid area of the arm. No adverse effects were reported. Additional information has been requested.
I developed COVID positive test; I developed COVID positive test; Had mild to moderate illness; This is a spontaneous report from a contactable physician reporting for himself. A 45-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) intramuscular, on 23Dec2020, single dose for COVID-19 immunization. Relevant medical history and concomitant medication was reported as none. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient was not diagnosed with COVID before vaccination. On 30Dec2020 at 4:15 PM, after the first vaccine dose, within a week the patient developed COVID positive test. The patient had mild to moderate illness on an unspecified date. Therapeutic measure taken in response to the events included administration of Tylenol. The patient underwent covid test via nasal swab on 31Dec2020 and showed positive result. Outcome of the events was not recovered.  Information for Lot/Batch number has been requested; Sender's Comments: The PFIZER-BIONTECH COVID-19 VACCINE provides protection after 7 days from the second dose.
Herpes Zoster (shingles) occurring 03/29/2002 involving left C-5, C-6 Dermatome area and the child went to ER and diagnosed with shingles. No reaction given and came to office 4-1-02 for follow up. See copies of record. No previous Varicella
Pt's left deltoid was swollen, hot and red from elbow to shoulder. He had a yellow scab noted at injection site. Complained of soreness and pain at site, also. Is well other than "local reaction". Referred to MD.
The mother phoned 4/6/00 that the child was at the baby sitter with shaking chills, fever 102, skin red with bumps. Child was taken to non emergency care at school. MD thought throat looked like strep, but screen was negative. All labs were negative. The pt was placed on antibiotics, child is improving, symptoms decreasing.
Patient states she woke up next morning following vaccine dizzy and nauseated. She didn't feel good. That evening she noticed her arm was red. Her arm is sore and couldn't sleep on it. The following night she slept better. Her arm was still red the second day after the vaccine. She went to the doctor for a visit and was told to report to the pharmacy her reaction.
Seizure, grand mal. 3 episodes 7 pm: 7 minutes 6/18/2015 1 am: 4 minutes 6:30 am: 2 minutes
This spontaneous report was received from a physician via a company representative and refers to a female patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date, the patient received an unspecified dose of pneumococcal vaccine injection (dose, route of administration, anatomical location, lot # and expiration date were not reported), for prophylaxis (reported as "vaccination").   On an unknown date after the vaccination, the patient developed a Guillain-Barre syndrome. The patient had been receiving an unspecified treatment for the event. The patient sought medical attention and seeing hers physician. At the time of the report, the event of Guillain-Barre syndrome was still ongoing. The causality assessment was not reported. Upon internal review, the event of Guillain-Barre syndrome was determined to be medically significant. Additional information is not expected since the reporter did not wish further contact.
Patient with a history of cardiomyopathy had an episode of chest tightness and shortness of breath after receiving the vaccine.
Possible vaccine failure I went in on 6/15/05 for a rash.  The Dr. though it looked like chickenpox.  He stated a possible break-through case.  The Dr's office completed blood test on 6/15/05.  The results came back neg. on 6/20/05 for immunity to varicella-zoster from lab.
started having diarrhea; cold sore lip; fever; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore arm), PYREXIA (fever), DIARRHOEA (started having diarrhea) and ORAL HERPES (cold sore lip) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced ARTHRALGIA (sore arm). On 20-Feb-2021, the patient experienced PYREXIA (fever). On 22-Feb-2021, the patient experienced DIARRHOEA (started having diarrhea) and ORAL HERPES (cold sore lip). On 21-Feb-2021, PYREXIA (fever) had resolved. On 22-Feb-2021, ARTHRALGIA (sore arm) had resolved. At the time of the report, DIARRHOEA (started having diarrhea) and ORAL HERPES (cold sore lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
AFTERNOON AFTER INJECTION SEVERE HEADACHE .. DAY 2 EVENING LOSS OF SMELL AND TASTE ALONG WITH UPPER LIP TIGHT AND TONGUE SWELLING AND JUST FEELS ODD.
I tested positive for COVID-19 on 4/22/23. I had a sore, scratchy throat, fever, congestion, and a cough. I took TYLENOL for the fever and took some cough drops. I contacted my doctor and was prescribed 5 days' worth of PAXLOVID. After finishing PAXLOVID, I had a rebound COVID-19 test. I am still dealing with this at this time. I am having sinus drainage, and congestion.
This spontaneous report was received from a Licensed Practical Nurse referring to a patient of unknown gender who would be 17 months old. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M023384 and expiration date on 20-JUL-2018 of lot # M033906 with expiration date on 06-JUN-2019 (dose and route of administration were not reported) for prophylaxis. The reporter could not provide details of which lot number the patient received. The doses of VARIVAX were exposed to a temperature excursion of 14.9 degrees Fahrenheit (°F) during a time frame of 11 hours, which was detected by the data logger. There was no prior temperature excursion and no adverse events were reported. This is one of the several reports received from the same source.; Sender's Comments: US-009507513-1710USA008686: US-009507513-1710USA008693: US-009507513-1710USA008688: US-009507513-1710USA001141: US-009507513-1710USA008690: US-009507513-1710USA008691: US-009507513-1710USA008692: US-009507513-1710USA008685: US-009507513-1710USA008684: US-009507513-1710USA008687:
woke up 3hrs post inj & was crying & screaming for approx 3hrs;
pt recv vax 27OCT98 & about week later arm started hurting lt arm;states last week was watching TV & saw show that said if you had had a flu shot & arm starts hurting afterwards to report to your provider ASAP;
2 doses of Boostrix received; Pregnant patient / 2 doses of Boostrix / 2-10/8/2020; Pregnant patient recdived 2 doses of Boostrix, first dose on  9/182020; This prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of vaccine exposure during pregnancy in a 31-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) (batch number Z59N7, expiry date 8th October 2022) for prophylaxis.   On 18th September 2020, the patient received the 1st dose of Boostrix. On 8th October 2020, the patient received the 2nd dose of Boostrix (intramuscular). The patient's last menstrual period was on 29th March 2020 and estimated date of delivery was 23rd December 2020. The patient received Boostrix at week 24 of the pregnancy. On 18th September 2020, not applicable after receiving Boostrix and unknown after receiving Boostrix, the patient experienced vaccine exposure during pregnancy. In October 2020, the patient experienced vaccine exposure during pregnancy. On an unknown date, the patient experienced extra dose administered. On an unknown date, the outcome of the vaccine exposure during pregnancy, vaccine exposure during pregnancy and extra dose administered were unknown. The pregnancy was ongoing.   Additional details were provided as follows: The age at vaccination was not reported. A nurse reported a pregnant patient came and received 2 doses of Boostrix one month apart which led to extra dose administered.  No symptoms reported. The reporter consented to follow up.
chills; headache that hurt so bad; body ache; fever of 100.9'F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache that hurt so bad), MYALGIA (body ache) and PYREXIA (fever of 100.9'F) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Liver enlargement, Hashimoto's disease and Fibromyalgia. Concomitant products included ATORVASTATIN for Cholesterol, GABAPENTIN, MELOXICAM and LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (headache that hurt so bad), MYALGIA (body ache) and PYREXIA (fever of 100.9'F). At the time of the report, CHILLS (chills), HEADACHE (headache that hurt so bad), MYALGIA (body ache) and PYREXIA (fever of 100.9'F) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment products - Patient took 1 Tylenol extra strength even though she was not supposed to due to enlarged liver. Patient also stated to have bodyache and fever of 100.9'F which went down to 99.8'F 6 hours later after taking Tylenol
Localized swelling, erythema, tenderness and induration around vaccination site. Occurred 2 days after vaccination and slowly worsening.  Concerned for cellulitis vs injection site rxn. Placed on oral abx, advised benadryl and OTC topical steroids PRN
pt recvd vax &noticed lesion on LL above shot site; pt had erythematous ring slight swelling, blisters in ctr;
100.2 fever, chills, soreness in left arm at site, body aches all over. These symptoms started around 2 am and continued throughout the morning
Tested positive to covid; Loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive to covid), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive to covid), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). At the time of the report, COVID-19 (Tested positive to covid), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Patient reported nausea 15 mins after vaccination and then experienced emesis x3 times. Patient stayed in clinic for 1 hour; reported headache and fatigue before leaving for home. RN and Paramedic discussed with patient ED precautions; to stay properly hydrated and to rest; patient reported understanding.
circle of warm, red, sore and swollen appeared next day after shot. Still swollen, sore, red and warm 2 days after shot (flu)
Patient suffered cardiac arrest, though most likely result of illicit substance use; patient had been feeling unwell with nausea and GI discomfort after receiving the vaccine 36 hours prior to; patient had been feeling unwell with nausea and GI discomfort after receiving the vaccine 36 hours prior to; patient had been feeling unwell with nausea and GI discomfort after receiving the vaccine 36 hours prior to; Patient suffered cardiac arrest, though most likely result of illicit substance use; This is a spontaneous report from a contactable physician. A 33-years-old male patient received bnt162b2 (BNT162B2, lot unknown), intramuscular on 14Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient suffered cardiac arrest 17Jan2021 11:15, though most likely result of illicit substance use since Jan2021, though patient had been feeling unwell with nausea and GI discomfort on 15Jan2021 23:15 after receiving the vaccine 36 hours prior to his arrest. The events were serious due to Life threatening illness (immediate risk of death from the event) and Disability or permanent damage. The patient had no COVID prior vaccination. COVID test type post vaccination=Nasal Swab on16Jan2021, test result was Negative. COVID test name post vaccination=Roche Cobas. The event outcome was not recovered. No treatment was received to events.  No follow-up attempts are possible; information on lot/batch number cannot be obtained.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events cardiac arrest, substance abuse, abdominal discomfort, malaise and nausea cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
PATIENT CALLED JUNE 10TH OF 2021 AND REPORTED HE HAD A SORENESS IN THE MIDDLE OF HIS BACK STARTING THE DAY AFTER THE COVID-19 JANSSEN VACCINATION. PATIENT REPORTED THE SORENESS IN HIS ARM WENT AWAY AFTER THE THIRD DAY FROM RECEIVING VACCINE. PATIENT REPORTED THE SORENESS IN THE MIDDLE OF HIS BACK CONTINUED TO BE SORE TO PAINFUL. PHARMACY HAS THE PATIENT RECEIVING VACCINE IN THE LEFT ARM. PATIENT REPORTED ABOUT A WEEK PRIOR TO HIM CALLING THE PHARMACY HIS LEFT ARM HAVING NUMBNESS AND NOW HIS HAND IS GOING NUMB. PHARMACY TOLD HIM TO CONTACT HIS DOCTOR. PHARMACY CHECK WITH PATIENT ON JUNE THE 11TH OF 2021 AND PATIENT STATED HE HAD MADE AN APPOINTMENT WITH HIS DOCTOR'S CLINIC.
3 days symptoms started 3 hours after vaccination - sore throat headache - warm -> cold - shaking - went to ER.
No adverse effects reported; patient was administered M-M-R II which was involved in a non-supported temperature slability evaluation.; This spontaneous report was received from a nurse regarding a currently 51-year-old female patient. There was no information reported regarding the patient's concomitant medication, pertinent medical history and drug reactions/allergies.   On 23-JUL-2019, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for prophylaxis, which was involved in a non- supported temperature stability evaluation (dose and route were not reported; lot number R036580 and expiration date 17-DEC-2020). The vaccine was reconstituted with properly stored STERILE DILUENT (lot number and expiration date were unknown by the reporter). The temperature was of 59 Fahrenheit degrees for a time frame of 6 hours. There was no previous temperature excursion. The call was because of a data logger. No adverse effects were reported.
Blisters across chest and on side of neck pt given Benadryl. Bandages applied to cover site.